ACCESSION: MSBNK-SMB_Measured-HSA015P0270000
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 33
COMMENT: RAW_SPEC {'Blanc1-pos_10683': {'bp': 367948.0, 'sum': 920345.0}, 'EL20_pos_10400': {'bp': 311512.0, 'sum': 678181.0}, 'EL16_pos_10395': {'bp': 245667.0, 'sum': 554178.0}, 'EL12_pos_10437': {'bp': 237981.0, 'sum': 543554.0}, 'EL14_pos_10407': {'bp': 230821.0, 'sum': 506542.0}, 'EL04_pos_10377': {'bp': 228531.0, 'sum': 504007.0}, 'EL22_pos_10509': {'bp': 226438.0, 'sum': 562398.0}, 'EL18_pos_10383': {'bp': 223541.0, 'sum': 482914.0}, 'EL23_pos_10401': {'bp': 215630.0, 'sum': 484667.0}, 'EL17_pos_10413': {'bp': 206171.0, 'sum': 454856.0}, 'EL19_pos_10480': {'bp': 200024.0, 'sum': 458338.0}, 'EL05_pos_10461': {'bp': 188972.0, 'sum': 439468.0}, 'EL21_pos_10419': {'bp': 183166.0, 'sum': 438743.0}, 'EL09_pos_10401': {'bp': 161953.0, 'sum': 363209.0}, 'EL11_pos_10384': {'bp': 159451.0, 'sum': 373970.0}, 'EL10_pos_10378': {'bp': 159448.0, 'sum': 360939.0}, 'EL07_pos_10389': {'bp': 153028.0, 'sum': 353349.0}, 'EL15_pos_10425': {'bp': 150298.0, 'sum': 380445.0}, 'EL02_pos_10480': {'bp': 147369.0, 'sum': 372555.0}, 'EL06_pos_10426': {'bp': 144353.0, 'sum': 365481.0}, 'Blanc3-pos_10313': {'bp': 142683.0, 'sum': 328611.0}, 'EL13_pos_10401': {'bp': 142506.0, 'sum': 333932.0}, 'EL08_pos_10389': {'bp': 139395.0, 'sum': 317378.0}, 'EL24_pos_10384': {'bp': 136443.0, 'sum': 326633.0}, 'EL01_pos_10377': {'bp': 135525.0, 'sum': 325496.0}, 'Blanc2-pos_10300': {'bp': 133430.0, 'sum': 327251.0}, 'EL08_pos_10444': {'bp': 73580.0, 'sum': 192274.0}, 'EL05_pos_10517': {'bp': 72887.0, 'sum': 188296.0}, 'EL04_pos_10432': {'bp': 70922.0, 'sum': 191948.0}, 'Blanc3-pos_10370': {'bp': 61498.0, 'sum': 173078.0}, 'EL15_pos_10487': {'bp': 60785.0, 'sum': 166451.0}, 'EL24_pos_10445': {'bp': 60572.0, 'sum': 152582.0}, 'EL01_pos_10438': {'bp': 56164.0, 'sum': 177649.0}}
COMMENT: RETENTION_TIME_STDEV 0.039
COMMENT: PRECURSOR_M/Z_RAW 270.279205
COMMENT: PRECURSOR_M/Z_STDEV 0.000098
COMMENT: PRECURSOR_IN_MS1 mz 270.279212; int 57.170; delta(ppm) 1.455265
COMMENT: PROPOSED_CHARGE_STATE +1; mz 271.282932; int 10.135; cor 0.917
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.245; C17H35NO; [M+H]+; delta(ppm) 0.245105
COMMENT: PROPOSED_MF MS-FINDER 3.731; C17H35NO; [M+H]+; delta(ppm) 0.243534
COMMENT: PROPOSED_MF SIRIUS5_Sirius 7.783; C17H35NO; [M+H]+; delta(ppm) 0.243534
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C17H35NO; [M+H]+; delta(ppm) 0.243534
COMMENT: PROPOSED_MF SIRIUS6_Sirius 14.278; C17H35NO; [M+H]+; delta(ppm) 0.243534
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.269; C15H33N4; [M+H]+; delta(ppm) 5.211252
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C17H35NO; [M+H]+; delta(ppm) 0.243534
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; YOWVGBBAXIJCDK-UHFFFAOYSA-N; C17H35NO; amylamine-C12:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.273; AKCDAPIBMHWMTN-UHFFFAOYSA-N; [M+H]+; O=C(NCC(C)CC)CCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.995; BHCDNJMTTHTRAU-UHFFFAOYSA-N; [M+H]+; O=C(NC(C)C)CCCCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.937; CYJLFSMDQYFKRD-UHFFFAOYNA-N; [M+H]+; CCCCC(CC)CN=C(O)CCCCCC(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.883; GNXLDJDDRKNQNQ-ISLYRVAYSA-N; [M+H]+; CCCCCCCCCCCCCCCC\C=N\O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.850; STEVSDAHHBNTQD-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCCCCC(=O)NC
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.362; AMLDBWWQKYLAHJ-UHFFFAOYSA-N; [M+H]+; Capsiamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.114; CYJLFSMDQYFKRD-UHFFFAOYNA-N; [M+H]+; N-(2-ethylhexyl)isononan-1-amide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.110; CRMQYXFOUKOYJO-UHFFFAOYSA-N; [M+H]+; Bacillamidin G
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.108; GNXLDJDDRKNQNQ-ISLYRVAYSA-N; [M+H]+; UNPD112235
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.045; AKCDAPIBMHWMTN-UHFFFAOYSA-N; [M+H]+; N-(2-methylbutyl)dodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.001; REEPJBYQLCWOAR-UHFFFAOYSA-N; [M+H]+; UNPD149831
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.994; STEVSDAHHBNTQD-UHFFFAOYSA-N; [M+H]+; UNPD150873
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.941; BHCDNJMTTHTRAU-UHFFFAOYSA-N; [M+H]+; N-(propan-2-yl)tetradecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; CYJLFSMDQYFKRD-UHFFFAOYNA-N; [M+H]+; N-(2-ethylhexyl)isononan-1-amide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.981; AKCDAPIBMHWMTN-UHFFFAOYSA-N; [M+H]+; N-(2-methylbutyl)dodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.970; AMLDBWWQKYLAHJ-UHFFFAOYSA-N; [M+H]+; Capsiamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.969; GNXLDJDDRKNQNQ-ISLYRVAYSA-N; [M+H]+; UNPD112235
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.969; REEPJBYQLCWOAR-UHFFFAOYSA-N; [M+H]+; UNPD149831
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.969; STEVSDAHHBNTQD-UHFFFAOYSA-N; [M+H]+; UNPD150873
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.969; CRMQYXFOUKOYJO-UHFFFAOYSA-N; [M+H]+; Bacillamidin G
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.969; BHCDNJMTTHTRAU-UHFFFAOYSA-N; [M+H]+; N-(propan-2-yl)tetradecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.970; AMLDBWWQKYLAHJ-UHFFFAOYSA-N; [M+H]+; N-(13-methyltetradecyl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.313; ZELXQOMIZMDPHB-UHFFFAOYSA-N; [M+H]+; 1-dodecyl-1-oxidopiperidin-1-ium
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.673; CYJLFSMDQYFKRD-UHFFFAOYSA-N; [M+H]+; N-(2-ethylhexyl)-7-methyloctanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.333; OKVLJDBLLKNOQZ-UHFFFAOYSA-N; [M+H]+; N-(2-ethylhexyl)-3,5,5-trimethylhexanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.304; NJRHNQQJFQCODE-UHFFFAOYSA-N; [M+H]+; N,N-bis(2-ethylhexyl)formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.303; MVSICBRQHSIVQP-UHFFFAOYSA-N; [M+H]+; 1-aminoheptadecan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.041; SYFWIANMZJPHOU-UHFFFAOYSA-N; [M+H]+; 2-propyl-N-(3-propylhexan-2-yl)pentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -41.284; REEPJBYQLCWOAR; [M+H]+; Heptadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -52.159; AKCDAPIBMHWMTN; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -81.223; STEVSDAHHBNTQD; [M+H]+; N-methylhexadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -82.365; CYJLFSMDQYFKRD; [M+H]+; Isononanamide, N-(2-ethylhexyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -93.619; BHCDNJMTTHTRAU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.500; MVSICBRQHSIVQP; [M+H]+; 1-amino-2-heptadecanon
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -116.775; GNXLDJDDRKNQNQ; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -119.520; AMLDBWWQKYLAHJ; [M+H]+; Capsiamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.694; ZELXQOMIZMDPHB; [M+H]+; 1-Dodecylpiperidine 1-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.938; SYFWIANMZJPHOU; [M+H]+; 2-Propyl-N-(3-propyl-2-hexyl)pentamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.917; VXYGFTZDXZHPHP; [M+H]+; 4-dodecyl-4-methylmorpholin-4-ium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -203.339; LVHAEMOCOJOUOD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.420; REEPJBYQLCWOAR; [M+H]+; Heptadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -149.022; GNXLDJDDRKNQNQ; [M+H]+; N-heptadecylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -199.533; AMLDBWWQKYLAHJ; [M+H]+; N-(13-methyltetradecyl)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -234.375; MVSICBRQHSIVQP; [M+H]+; 1-Deoxymethyl-3-dehydrosphinganine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.079; ZELXQOMIZMDPHB; [M+H]+; 1-Dodecylpiperidine 1-oxide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -241.695; LVHAEMOCOJOUOD; [M+H]+; 2,6-Dimethyl-4-undecylmorpholine, trans-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -242.030; REEPJBYQLCWOAR; [M+H]+; heptadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -248.392; CYJLFSMDQYFKRD; [M+H]+; N-[(2R)-2-ethylhexyl]-7-methyloctanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -294.688; BHCDNJMTTHTRAU; [M+H]+; N-(propan-2-yl)tetradecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -298.914; STEVSDAHHBNTQD; [M+H]+; N-methylhexadecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -308.952; CRMQYXFOUKOYJO; [M+H]+; Bacillamidin G
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.334; GNXLDJDDRKNQNQ; [M+H]+; N-heptadecylidenehydroxylamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C17H36N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.980
MS$FOCUSED_ION: PRECURSOR_M/Z 270.279207
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-00di-5190000000-12282ebbacd7d885f03b
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0545154 23.0301 55.055223 1.3260 13.89 0.1976 28 f{C4H7}/5.25ppm,p-C13H29N1O1
  57.0701435 324.0145 57.070860 0.3504 27.25 0.9723 33 f{C4H9}/4.68ppm,p-C13H27N1O1
  69.0700080 24.7428 69.070751 1.2741 13.15 0.6043 29 f{C5H9}/1.90ppm,p-C12H27N1O1
  71.0856668 258.5131 71.086410 0.4502 35.03 0.9582 33 f{C5H11}/1.97ppm,p-C12H25N1O1
  81.0699792 27.6258 81.070706 1.3445 15.75 0.3880 27 f{C6H9}/1.26ppm,p-C11H27N1O1
  95.0855146 25.8521 95.086167 1.4408 16.25 0.2393 27 f{C7H11}/-0.13ppm,p-C10H25N1O1
  158.1539667 211.9819 158.154290 0.8093 34.48 0.9718 32 f{C9H20N1O1}/0.16ppm,p-C8H16
  270.2791539 999.0000 270.279540 0.3034 0.00 1.0000 33 f{C17H36N1O1}/0.05ppm,p
  271.2824830 136.4939 271.282870 0.9842 10.43 0.9577 31 ?
PK$NUM_PEAK: 9
PK$PEAK: m/z int. rel.int.
  55.054515 23.03 23
  57.070144 324.01 324
  69.070008 24.74 24
  71.085667 258.51 258
  81.069979 27.63 27
  95.085515 25.85 25
  158.153967 211.98 211
  270.279154 999.00 999
  271.282483 136.49 136
//
